Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 42


The treatment outcomes of antiretroviral substitutions in routine clinical settings in Asia; data from the TREAT Asia HIV Observational Database (TAHOD).

Jung IY, Boettiger D, Wong WW, Lee MP, Kiertiburanakul S, Chaiwarith R, Avihingsanon A, Tanuma J, Kumarasamy N, Kamarulzaman A, Zhang F, Kantipong P, Ng OT, Sim BLH, Law M, Ross J, Choi JY.

J Int AIDS Soc. 2017 Dec;20(4). doi: 10.1002/jia2.25016.


The incidence of first-line antiretroviral treatment changes and related factors among HIV-infected sex workers in Nairobi, Kenya.

Ndakala FN, Oyugi JO, Oluka MN, Kimani J, Norbert Behrens GM.

Pan Afr Med J. 2017 Sep 5;28:7. doi: 10.11604/pamj.2017.28.7.10885. eCollection 2017.


Real-world persistence with antiretroviral therapy for HIV in the United Kingdom: A multicentre retrospective cohort study.

Lewis JM, Smith C, Torkington A, Davies C, Ahmad S, Tomkins A, Shaw J, Kingston M, Muqbill G, Hay P, Mulka L, Williams D, Waters L, Brima N, Marshall N, Johnson M, Chaponda M, Nelson M.

J Infect. 2017 Apr;74(4):401-407. doi: 10.1016/j.jinf.2017.01.012. Epub 2017 Jan 29.


Population Pharmacokinetic Modeling To Estimate the Contributions of Genetic and Nongenetic Factors to Efavirenz Disposition.

Robarge JD, Metzger IF, Lu J, Thong N, Skaar TC, Desta Z, Bies RR.

Antimicrob Agents Chemother. 2016 Dec 27;61(1). pii: e01813-16. doi: 10.1128/AAC.01813-16. Print 2017 Jan.


Association Between the Occurrence of Adverse Drug Events and Modification of First-Line Highly Active Antiretroviral Therapy in Ghanaian HIV Patients.

Tetteh RA, Nartey ET, Lartey M, Mantel-Teeuwisse AK, Leufkens HG, Yankey BA, Dodoo AN.

Drug Saf. 2016 Nov;39(11):1139-1149.


Saquinavir Loaded Acetalated Dextran Microconfetti - a Long Acting Protease Inhibitor Injectable.

Collier MA, Gallovic MD, Bachelder EM, Sykes CD, Kashuba A, Ainslie KM.

Pharm Res. 2016 Aug;33(8):1998-2009. doi: 10.1007/s11095-016-1936-y. Epub 2016 May 6.


Long-Term Efficacy, Tolerability, and Renal Safety of Atazanavir/Ritonavir-based Antiretroviral Therapy in a Cohort of Treatment-Naïve Patients with HIV-1 Infection: the REMAIN Study.

Teófilo E, Rocha-Pereira N, Kuhlmann B, Antela A, Knechten H, Santos J, Jiménez-Expósito MJ; REMAIN study group.

HIV Clin Trials. 2016 Feb;17(1):17-28. doi: 10.1080/15284336.2015.1112494.


Discontinuation of Initial Antiretroviral Therapy in Clinical Practice: Moving Toward Individualized Therapy.

Di Biagio A, Cozzi-Lepri A, Prinapori R, Angarano G, Gori A, Quirino T, De Luca A, Costantini A, Mussini C, Rizzardini G, Castagna A, Antinori A, dʼArminio Monforte A; ICONA Foundation Study Group.

J Acquir Immune Defic Syndr. 2016 Mar 1;71(3):263-71. doi: 10.1097/QAI.0000000000000849.


Factors associated with the first antiretroviral therapy modification in older HIV-1 positive patients.

Kowalska JD, Kubicka J, Siwak E, Pulik P, Firląg-Burkacka E, Horban A; Polish Observational Cohort of HIV/AIDS Patients (POLCA) Study Group.

AIDS Res Ther. 2016 Jan 7;13:2. doi: 10.1186/s12981-015-0084-5. eCollection 2016.


Progression of Liver Fibrosis and Modern Combination Antiretroviral Therapy Regimens in HIV-Hepatitis C-Coinfected Persons.

Brunet L, Moodie EEM, Young J, Cox J, Hull M, Cooper C, Walmsley S, Martel-Laferrière V, Rachlis A, Klein MB; Canadian Co-infection Cohort Study, Cohen J, Conway B, Cooper C, Côté P, Cox J, Gill J, Haider S, Sadr A, Johnston L, Hull M, Montaner J, Moodie E, Pick N, Rachlis A, Rouleau D, Sandre R, Tyndall JM, Vachon ML, Sanche S, Skinner S, Wong D.

Clin Infect Dis. 2016 Jan 15;62(2):242-249. doi: 10.1093/cid/civ838. Epub 2015 Sep 23.


Reasons and Risk Factors for the Initial Regimen Modification in Chinese Treatment-Naïve Patients with HIV Infection: A Retrospective Cohort Analysis.

Sun J, Liu L, Shen J, Qi T, Wang Z, Song W, Zhang R, Lu H.

PLoS One. 2015 Jul 24;10(7):e0133242. doi: 10.1371/journal.pone.0133242. eCollection 2015.


Incidence and predictors of regimen-modification from first-line antiretroviral therapy in Thailand: a cohort study.

Tsuchiya N, Pathipvanich P, Wichukchinda N, Rojanawiwat A, Auwanit W, Ariyoshi K, Sawanpanyalert P.

BMC Infect Dis. 2014 Oct 30;14:565. doi: 10.1186/s12879-014-0565-5.


Budget impact analysis of antiretroviral less drug regimen simplification in HIV-positive patients on the Italian National Health Service.

Restelli U, Andreoni M, Antinori A, Bonfanti M, Di Perri G, Galli M, Lazzarin A, Rizzardini G, Croce D.

Clinicoecon Outcomes Res. 2014 Sep 23;6:409-14. doi: 10.2147/CEOR.S68101. eCollection 2014.


Lopinavir/r no longer recommended as a first-line regimen: a comparative effectiveness analysis.

Potard V, Rey D, Poizot-Martin I, Mokhtari S, Pradier C, Rozenbaum W, Brun-Vezinet F, Costagliola D; FHDH ANRS CO4 (French Hospital Database on HIV, Agence Nationale de Recherches sur le Sida, cohort 4).

J Int AIDS Soc. 2014 Sep 25;17:19070. doi: 10.7448/IAS.17.1.19070. eCollection 2014.


Cobicistat: a Novel Pharmacoenhancer for Co-Formulation with HIV Protease and Integrase Inhibitors.

Nathan B, Bayley J, Waters L, Post FA.

Infect Dis Ther. 2013 Dec;2(2):111-22. doi: 10.1007/s40121-013-0013-7. Epub 2013 Sep 3.


Temporal trends in the discontinuation of first-line antiretroviral therapy.

Gonzalez-Serna A, Chan K, Yip B, Chau W, McGovern R, Samji H, Lima VD, Hogg RS, Harrigan R.

J Antimicrob Chemother. 2014 Aug;69(8):2202-9. doi: 10.1093/jac/dku112. Epub 2014 Apr 15.


Incidence and predictors of first line antiretroviral regimen modification in western Kenya.

Inzaule S, Otieno J, Kalyango J, Nafisa L, Kabugo C, Nalusiba J, Kwaro D, Zeh C, Karamagi C.

PLoS One. 2014 Apr 2;9(4):e93106. doi: 10.1371/journal.pone.0093106. eCollection 2014.


Influence of adverse drug reactions on treatment success: prospective cohort analysis of HIV-infected individuals initiating first-line antiretroviral therapy in India.

Shet A, Antony J, Arumugam K, Kumar Dodderi S, Rodrigues R, DeCosta A.

PLoS One. 2014 Mar 10;9(3):e91028. doi: 10.1371/journal.pone.0091028. eCollection 2014.


Changes in first-line cART regimens and short-term clinical outcome between 1996 and 2010 in The Netherlands.

Smit M, Smit C, Geerlings S, Gras L, Brinkman K, Hallett TB, de Wolf F; Athena Observational Cohort.

PLoS One. 2013 Sep 30;8(9):e76071. doi: 10.1371/journal.pone.0076071. eCollection 2013.

Supplemental Content

Support Center